Th. Burkey et al., RELATIVE EFFICACIES OF CANNABINOID CB1 RECEPTOR AGONISTS IN THE MOUSE-BRAIN, European journal of pharmacology, 336(2-3), 1997, pp. 295-298
We measured 2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-phenol (CP 55,
940)-, (-)11-OH-Delta (8)-tetrahydrocannabinol-dimethylheptyl (HU-210)
-, anandamide- and Delta(9)-tetrahydrocannabinol-stimulated G protein
activation in mouse brain using the [S-35]GTPyS functional assay. The
K-i values for these drugs were determined by agonist competition bind
ing with the cannabinoid CB, receptor antagonist l)-4-methyl-1H-pyrazo
le-3-carboxamidehydrochloride ([H-3]SR141716A). This information was u
sed to calculate the efficacy for drug stimulation of G protein activi
ty. The rank order of efficacy was CP 55,940 > HU-210 > anandamide > D
elta(9)-tetrahydrocannabinol with the latter two drugs being partial a
gonists. Since efficacy values relate receptor occupancy to functional
responses, we believe efficacy values are a better measure of drug-me
diated functional responses compared with measurements of drug potency
. (C) 1997 Elsevier Science B.V.